Clinical

Dataset Information

TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer


ABSTRACT: This is a Phase II, non-randomized, open-label study to evaluate temozolomide in combination with olaparib in patients with MGMT promoter hypermethylated advanced colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2322183 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR